Published on
12:33 GMT
<![CDATA[Top Poster Takeaways for Urothelial Carcinoma From The 2026 ESMO Congress]]>
In patients with a GFR of 90 mL/min or higher (n = 179), median OS was NE with the combination (95% CI, 29.6-NE) vs 18.6 months (95% CI, 14.5-28.6) with chemotherapy (HR, 0.49; 95% CI, 0.33-0.74). In those with a GFR of 60 to below 90 mL/min (n = …
Source:
Cancer Network - New Jersey
-
Pending
